skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 82  for All Library Resources

Results 1 2 3 4 5 next page
Refined by: resource type: Web Resources remove subject: Valuation remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Ticker Report - American Consumer News: Comparing Crinetics Pharmaceuticals (NASDAQ:CRNX) & Heron Therapeutics (NASDAQ:HRTX)
Material Type:
Web Resources
Add to My Research

Ticker Report - American Consumer News: Comparing Crinetics Pharmaceuticals (NASDAQ:CRNX) & Heron Therapeutics (NASDAQ:HRTX)

Newstex Finance & Accounting Blogs, 2023

Copyright Newstex Aug 12, 2023

Digital Resources/Online E-Resources

2
American Banking and Market News - American Consumer News: Heron Therapeutics (NASDAQ:HRTX) & Crinetics Pharmaceuticals (NASDAQ:CRNX) Financial Analysis
Material Type:
Web Resources
Add to My Research

American Banking and Market News - American Consumer News: Heron Therapeutics (NASDAQ:HRTX) & Crinetics Pharmaceuticals (NASDAQ:CRNX) Financial Analysis

Newstex Finance & Accounting Blogs, 2023

Copyright Newstex Aug 10, 2023

Digital Resources/Online E-Resources

3
Zolmax.com - American Consumer News: Comparing Allarity Therapeutics (NASDAQ:ALLR) and Crinetics Pharmaceuticals (NASDAQ:CRNX)
Material Type:
Web Resources
Add to My Research

Zolmax.com - American Consumer News: Comparing Allarity Therapeutics (NASDAQ:ALLR) and Crinetics Pharmaceuticals (NASDAQ:CRNX)

Newstex Global Business Blogs, 2023

Copyright Newstex Jun 29, 2023

Digital Resources/Online E-Resources

4
Ticker Report - American Consumer News: Neurocrine Biosciences (NASDAQ:NBIX) & Genfit (NASDAQ:GNFT) Head-To-Head Review
Material Type:
Web Resources
Add to My Research

Ticker Report - American Consumer News: Neurocrine Biosciences (NASDAQ:NBIX) & Genfit (NASDAQ:GNFT) Head-To-Head Review

Newstex Finance & Accounting Blogs, 2024

Copyright Newstex Mar 24, 2024

Digital Resources/Online E-Resources

5
American Banking and Market News - American Consumer News: Analyzing Editas Medicine (NASDAQ:EDIT) & ProKidney (NASDAQ:PROK)
Material Type:
Web Resources
Add to My Research

American Banking and Market News - American Consumer News: Analyzing Editas Medicine (NASDAQ:EDIT) & ProKidney (NASDAQ:PROK)

Newstex Finance & Accounting Blogs, 2022

Copyright Newstex Dec 25, 2022

Digital Resources/Online E-Resources

6
Zolmax.com - American Consumer News: Reviewing Editas Medicine (NASDAQ:EDIT) & ProKidney (NASDAQ:PROK)
Material Type:
Web Resources
Add to My Research

Zolmax.com - American Consumer News: Reviewing Editas Medicine (NASDAQ:EDIT) & ProKidney (NASDAQ:PROK)

Newstex Global Business Blogs, 2022

Copyright Newstex Dec 25, 2022

Digital Resources/Online E-Resources

7
American Banking and Market News - American Consumer News: Comparing ProKidney (NASDAQ:PROK) & Editas Medicine (NASDAQ:EDIT)
Material Type:
Web Resources
Add to My Research

American Banking and Market News - American Consumer News: Comparing ProKidney (NASDAQ:PROK) & Editas Medicine (NASDAQ:EDIT)

Newstex Finance & Accounting Blogs, 2022

Copyright Newstex Dec 25, 2022

Digital Resources/Online E-Resources

8
Zolmax.com - American Consumer News: Head to Head Contrast: ProKidney (NASDAQ:PROK) and Editas Medicine (NASDAQ:EDIT)
Material Type:
Web Resources
Add to My Research

Zolmax.com - American Consumer News: Head to Head Contrast: ProKidney (NASDAQ:PROK) and Editas Medicine (NASDAQ:EDIT)

Newstex Global Business Blogs, 2022

Copyright Newstex Dec 25, 2022

Digital Resources/Online E-Resources

9
Watchlist News - American Consumer News: Analyzing Editas Medicine (NASDAQ:EDIT) & ProKidney (NASDAQ:PROK)
Material Type:
Web Resources
Add to My Research

Watchlist News - American Consumer News: Analyzing Editas Medicine (NASDAQ:EDIT) & ProKidney (NASDAQ:PROK)

Newstex Finance & Accounting Blogs, 2022

Copyright Newstex Dec 23, 2022

Digital Resources/Online E-Resources

10
Ticker Report - American Consumer News: Comparing Editas Medicine (NASDAQ:EDIT) & ProKidney (NASDAQ:PROK)
Material Type:
Web Resources
Add to My Research

Ticker Report - American Consumer News: Comparing Editas Medicine (NASDAQ:EDIT) & ProKidney (NASDAQ:PROK)

Newstex Finance & Accounting Blogs, 2022

Copyright Newstex Dec 23, 2022

Digital Resources/Online E-Resources

11
Zolmax.com - American Consumer News: AbCellera Biologics (NASDAQ:ABCL) vs. Crinetics Pharmaceuticals (NASDAQ:CRNX) Head to Head Review
Material Type:
Web Resources
Add to My Research

Zolmax.com - American Consumer News: AbCellera Biologics (NASDAQ:ABCL) vs. Crinetics Pharmaceuticals (NASDAQ:CRNX) Head to Head Review

Newstex Global Business Blogs, 2023

Copyright Newstex Nov 8, 2023

Digital Resources/Online E-Resources

12
Zolmax.com - American Consumer News: Reviewing Crinetics Pharmaceuticals (NASDAQ:CRNX) and Syndax Pharmaceuticals (NASDAQ:SNDX)
Material Type:
Web Resources
Add to My Research

Zolmax.com - American Consumer News: Reviewing Crinetics Pharmaceuticals (NASDAQ:CRNX) and Syndax Pharmaceuticals (NASDAQ:SNDX)

Newstex Global Business Blogs, 2023

Copyright Newstex Sep 12, 2023

Digital Resources/Online E-Resources

13
American Banking and Market News - American Consumer News: Syndax Pharmaceuticals (NASDAQ:SNDX) versus Crinetics Pharmaceuticals (NASDAQ:CRNX) Critical Review
Material Type:
Web Resources
Add to My Research

American Banking and Market News - American Consumer News: Syndax Pharmaceuticals (NASDAQ:SNDX) versus Crinetics Pharmaceuticals (NASDAQ:CRNX) Critical Review

Newstex Finance & Accounting Blogs, 2023

Copyright Newstex Sep 12, 2023

Digital Resources/Online E-Resources

14
Watchlist News - American Consumer News: Crinetics Pharmaceuticals (NASDAQ:CRNX) vs. Syndax Pharmaceuticals (NASDAQ:SNDX) Head to Head Analysis
Material Type:
Web Resources
Add to My Research

Watchlist News - American Consumer News: Crinetics Pharmaceuticals (NASDAQ:CRNX) vs. Syndax Pharmaceuticals (NASDAQ:SNDX) Head to Head Analysis

Newstex Finance & Accounting Blogs, 2023

Copyright Newstex Sep 9, 2023

Digital Resources/Online E-Resources

15
Ticker Report - American Consumer News: Head-To-Head Contrast: Disc Medicine Opco (NASDAQ:IRON) versus Spruce Biosciences (NASDAQ:SPRB)
Material Type:
Web Resources
Add to My Research

Ticker Report - American Consumer News: Head-To-Head Contrast: Disc Medicine Opco (NASDAQ:IRON) versus Spruce Biosciences (NASDAQ:SPRB)

Newstex Finance & Accounting Blogs, 2023

Copyright Newstex Aug 25, 2023

Digital Resources/Online E-Resources

16
Watchlist News - American Consumer News: Spruce Biosciences (NASDAQ:SPRB) versus Disc Medicine Opco (NASDAQ:IRON) Head to Head Comparison
Material Type:
Web Resources
Add to My Research

Watchlist News - American Consumer News: Spruce Biosciences (NASDAQ:SPRB) versus Disc Medicine Opco (NASDAQ:IRON) Head to Head Comparison

Newstex Finance & Accounting Blogs, 2023

Copyright Newstex Aug 25, 2023

Digital Resources/Online E-Resources

17
Zolmax.com - American Consumer News: Reviewing Crinetics Pharmaceuticals (NASDAQ:CRNX) and Heron Therapeutics (NASDAQ:HRTX)
Material Type:
Web Resources
Add to My Research

Zolmax.com - American Consumer News: Reviewing Crinetics Pharmaceuticals (NASDAQ:CRNX) and Heron Therapeutics (NASDAQ:HRTX)

Newstex Global Business Blogs, 2023

Copyright Newstex Aug 10, 2023

Digital Resources/Online E-Resources

18
Watchlist News - American Consumer News: Reviewing Crinetics Pharmaceuticals (NASDAQ:CRNX) and Heron Therapeutics (NASDAQ:HRTX)
Material Type:
Web Resources
Add to My Research

Watchlist News - American Consumer News: Reviewing Crinetics Pharmaceuticals (NASDAQ:CRNX) and Heron Therapeutics (NASDAQ:HRTX)

Newstex Finance & Accounting Blogs, 2023

Copyright Newstex Aug 10, 2023

Digital Resources/Online E-Resources

19
Ticker Report - American Consumer News: Analyzing Heron Therapeutics (NASDAQ:HRTX) and Crinetics Pharmaceuticals (NASDAQ:CRNX)
Material Type:
Web Resources
Add to My Research

Ticker Report - American Consumer News: Analyzing Heron Therapeutics (NASDAQ:HRTX) and Crinetics Pharmaceuticals (NASDAQ:CRNX)

Newstex Finance & Accounting Blogs, 2023

Copyright Newstex Aug 12, 2023

Digital Resources/Online E-Resources

20
Watchlist News - American Consumer News: Head to Head Contrast: Allarity Therapeutics (NASDAQ:ALLR) & Crinetics Pharmaceuticals (NASDAQ:CRNX)
Material Type:
Web Resources
Add to My Research

Watchlist News - American Consumer News: Head to Head Contrast: Allarity Therapeutics (NASDAQ:ALLR) & Crinetics Pharmaceuticals (NASDAQ:CRNX)

Newstex Finance & Accounting Blogs, 2023

Copyright Newstex Jul 1, 2023

Digital Resources/Online E-Resources

Results 1 - 20 of 82  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Refine My Results

Creation Date 

From To
  1. Before 2018  (1)
  2. 2018 To 2018  (2)
  3. 2019 To 2019  (2)
  4. 2020 To 2021  (18)
  5. After 2021  (60)
  6. More options open sub menu

Searching Remote Databases, Please Wait